Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed the transcript of the Earnings call held on Monday, May 29, 2023 at 11.00 am IST to discuss operational and financial performance of the Company for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23).
The above information is a part of company’s filings submitted to BSE.